Acorda Therapeutics Inc. ACOR shares are jumping after news hit the wires that Biogen Idec BIIB may be looking for a partner in multiple sclerosis drugs.
At last check, shares of Acorda Therapeutics were up $1.06 to $31.94, a gain of around 3%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
